Anonymousabout 2 hours ago
After 14 years of debate involving 22,000 stakeholders across 56 organizations, polycystic ovary syndrome (PCOS) has been formally renamed polyendocrine metabolic ovarian syndrome (PMOS) in a Lancet paper published May 12, 2026. The change aims to correct a misleading name that contributed to diagnostic delays affecting up to 70% of the estimated 170 million women with the condition worldwide, but critics warn the rename carries real risks to clinical infrastructure, insurance coding, and patient support networks that have not been adequately assessed.